Background & Aims: Helicobacter pylori infection increases gastric regulatory T cell (Treg) response, which may contribute to H pylori immune escape. We hypothesize that H pylori directs Treg skewing by way of dendritic cells (DCs) and thus inhibits interleukin-17(+) helper T cells (Th17) immunity.
Methods: Two-photon microscopy was used to locate DCs in gastric lamina propria of mice. The induction of Th17 and Treg responses by bacteria-pulsed murine bone marrow-derived DCs was analyzed by cytokine production and stimulation of T-cell proliferation. The effect of VacA, CagA, transforming growth factor-beta (TGF-beta), and IL-10 on Th17/Treg balance was assessed. The in vivo significance of Tregs on the H pylori-specific Th17 response and H pylori density was determined by using anti-CD25 neutralizing antibodies to deplete Tregs in mice.
Results: We showed that mucosal CD11c(+) DCs are located near the surface of normal gastric epithelium, and their number increased after H pylori infection. Study of the direct interaction of DCs with H pylori showed a Treg-skewed response. The Treg skewing was independent of H pylori VacA and CagA and dependent on TGF-beta and IL-10. In vivo Treg skewing by adoptive transfer of H pylori-pulsed DCs reduces the ratio of gastric IL-17/Foxp3 mRNA expressions. The depletion of CD25(+) Tregs results in early reduction of H pylori density, which is correlated with enhanced peripheral H pylori-specific Th17, but not Th1, response.
Conclusions: Overall, our study indicates that H pylori alters the DC-polarized Th17/Treg balance toward a Treg-biased response, which suppresses the effective induction of H pylori-specific Th17 immunity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831148 | PMC |
| http://dx.doi.org/10.1053/j.gastro.2009.11.043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism.
Biomed Pharmacother
December 2024
Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Electronic address:
Article Synopsis
- The dysbiotic gut microbiota and bile acids play a crucial role in the immune dysfunction seen in inflammatory bowel disease (IBD), as shown by changes in bile acid excretion and gut microbiota composition.
- Elevated primary bile acids and reduced secondary bile acids were linked to increased disease severity and inflammatory responses in IBD patients and murine colitis models.
- The study identified five specific bile acids that, when administered, could reverse colitis and intestinal dysbiosis, suggesting the potential for treatments targeting bile acid profiles in managing IBD.
High Extracellular K Skews T-Cell Differentiation Towards Tumour Promoting Th2 and T Subsets.
Eur J Immunol
December 2024
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Potassium ions (K) released from dying necrotic tumour cells accumulate in the tumour microenvironment (TME) and increase the local K concentration to 50 mM (high-[K]). Here, we demonstrate that high-[K] decreases expression of the T-cell receptor subunits CD3ε and CD3ζ and co-stimulatory receptor CD28 and thereby dysregulates intracellular signal transduction cascades. High-[K] also alters the metabolic profiles of T-cells, limiting the metabolism of glucose and glutamine, consistent with functional exhaustion.
View Article and Find Full Text PDFThe gut core microbial species Bifidobacterium longum: Colonization, mechanisms, and health benefits.
Microbiol Res
January 2025
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, PR China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, PR China; National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214122, PR China.
Bifidobacterium longum (B. longum) is a species of the core microbiome in the human gut, whose abundance is closely associated with host age and health status. B.
View Article and Find Full Text PDFIdentification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy.
J Autoimmun
December 2024
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Immunology, University of Washington, Seattle, WA, USA. Electronic address:
Article Synopsis
- Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease primarily affecting small bile ducts, with limited treatment options and a reliance on liver transplants in severe cases.
- Researchers studied T cell responses to a specific protein (PDC-E2) linked to PBC, focusing on a common genetic marker (HLA Class II DRB4∗01:01) found in many patients.
- They discovered unique T cell receptors (TCRs) that can target a new PDC-E2 epitope, leading to the development of engineered regulatory T cells (EngTreg) that could help suppress harmful immune responses in PBC patients, offering potential for new therapies.
Administration of rIL-33 Restores Altered mDC/pDC Ratio, MDSC Frequency, and Th-17/Treg Ratio during Experimental Cerebral Malaria.
Pathogens
October 2024
Immunology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700019, West Bengal, India.
The onset of malaria causes the induction of various inflammatory markers in the host's body, which in turn affect the body's homeostasis and create several cerebral complications. Polarization of myeloid-derived suppressor cells (MDSCs) from the classically activated M1 to alternatively activated M2 phenotype increases the secretion of pro-inflammatory molecules. Treatment with recombinant IL-33 (rIL-33) not only alters this MDSC's polarization but also targets the glycolysis pathway of the metabolism in MDSCs, rendering them less immunosuppressive.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!